Examining BRITEpath, a Digital Intervention for Reducing Adolescent Suicide Risk in Primary Care: A Randomized-Controlled Trial.

INTRODUCTION

Previous research has identified a high need for suicide risk management in primary care settings among adolescents. This randomized controlled trial examined the efficacy and feasibility of BRITEpath, a smartphone-based application and clinician portal designed to help youth in reducing suicide risk.

METHODS

Participants (n = 101, ages 12-26, 85.1% female) that were either referred to or were receiving mental health services in primary care were randomly assigned (2:1 allocation) to BRITEpath + TAU (n = 68) or TAU alone (n = 33). Independent evaluators, blinded to treatment, assessed outcomes at baseline, Week 4, and Week 12. Primary outcomes included suicidal thoughts and behaviors, depression, mental health service use, and quality of life; secondary outcomes examined usability and satisfaction.

RESULTS

No significant differences were found between BRITEpath + TAU and TAU for primary outcomes overall. However, BRITEpath participants reported lower suicidal thoughts over time. History of inpatient and outpatient care moderated the effect of BRITEpath on depression. Participants reported high satisfaction and perceived usefulness of the app.

CONCLUSIONS

BRITEpath shows promising effects on suicidal thoughts and depression, particularly among those with prior psychiatric care. Future research should explore strategies to enhance engagement, such as integration with ongoing care, which may strengthen the impact on clinical outcomes.

TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04672798.